Selection of target sites for mobile DNA integration in the human genome
- PMID: 17166054
- PMCID: PMC1664696
- DOI: 10.1371/journal.pcbi.0020157
Selection of target sites for mobile DNA integration in the human genome
Abstract
DNA sequences from retroviruses, retrotransposons, DNA transposons, and parvoviruses can all become integrated into the human genome. Accumulation of such sequences accounts for at least 40% of our genome today. These integrating elements are also of interest as gene-delivery vectors for human gene therapy. Here we present a comprehensive bioinformatic analysis of integration targeting by HIV, MLV, ASLV, SFV, L1, SB, and AAV. We used a mathematical method which allowed annotation of each base pair in the human genome for its likelihood of hosting an integration event by each type of element, taking advantage of more than 200 types of genomic annotation. This bioinformatic resource documents a wealth of new associations between genomic features and integration targeting. The study also revealed that the length of genomic intervals analyzed strongly affected the conclusions drawn--thus, answering the question "What genomic features affect integration?" requires carefully specifying the length scale of interest.
Conflict of interest statement
Figures






Similar articles
-
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.PLoS Biol. 2004 Aug;2(8):E234. doi: 10.1371/journal.pbio.0020234. Epub 2004 Aug 17. PLoS Biol. 2004. PMID: 15314653 Free PMC article.
-
Human T-cell leukemia virus type 1 integration target sites in the human genome: comparison with those of other retroviruses.J Virol. 2007 Jun;81(12):6731-41. doi: 10.1128/JVI.02752-06. Epub 2007 Apr 4. J Virol. 2007. PMID: 17409138 Free PMC article.
-
VISDB: a manually curated database of viral integration sites in the human genome.Nucleic Acids Res. 2020 Jan 8;48(D1):D633-D641. doi: 10.1093/nar/gkz867. Nucleic Acids Res. 2020. PMID: 31598702 Free PMC article.
-
Targeting survival: integration site selection by retroviruses and LTR-retrotransposons.Cell. 2003 Oct 17;115(2):135-8. doi: 10.1016/s0092-8674(03)00760-8. Cell. 2003. PMID: 14567911 Review.
-
Integration site selection by retroviruses and transposable elements in eukaryotes.Nat Rev Genet. 2017 May;18(5):292-308. doi: 10.1038/nrg.2017.7. Epub 2017 Mar 13. Nat Rev Genet. 2017. PMID: 28286338 Review.
Cited by
-
Transient Expression of an LEDGF/p75 Chimera Retargets Lentivector Integration and Functionally Rescues in a Model for X-CGD.Mol Ther Nucleic Acids. 2013 Mar 5;2(3):e77. doi: 10.1038/mtna.2013.4. Mol Ther Nucleic Acids. 2013. PMID: 23462964 Free PMC article.
-
Integration of HIV in the Human Genome: Which Sites Are Preferential? A Genetic and Statistical Assessment.Int J Genomics. 2016;2016:2168590. doi: 10.1155/2016/2168590. Epub 2016 May 12. Int J Genomics. 2016. PMID: 27294106 Free PMC article.
-
Retroviral Integrase Structure and DNA Recombination Mechanism.Microbiol Spectr. 2014;2(6):1-22. doi: 10.1128/microbiolspec.MDNA3-0024-2014.. Microbiol Spectr. 2014. PMID: 25705574 Free PMC article.
-
rDNA-directed integration by an HIV-1 integrase--I-PpoI fusion protein.Nucleic Acids Res. 2013 Mar 1;41(5):e61. doi: 10.1093/nar/gks1438. Epub 2012 Dec 28. Nucleic Acids Res. 2013. PMID: 23275537 Free PMC article.
-
Comparative analysis of the recently discovered hAT transposon TcBuster in human cells.PLoS One. 2012;7(11):e42666. doi: 10.1371/journal.pone.0042666. Epub 2012 Nov 15. PLoS One. 2012. PMID: 23166581 Free PMC article.
References
-
- Lander ES, Linton LM, Birren B, Nusbaum C, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. - PubMed
-
- Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. The sequence of the human genome. Science. 2001;291:1304–1351. - PubMed
-
- Craig NL, Craigie R, Gellert M, Lambowitz AM, editors. Mobile DNA II. Washington (D.C.): ASM Press; 2002. 1204
-
- Bushman FD. Lateral DNA transfer: Mechanisms and consequences. New York: Cold Spring Harbor Laboratory Press; 2001. 448
-
- Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med. 2003;348:255–256. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources